Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 4/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.46 |
| ▸ | NT5E | P21589 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 6/20 | 0.37 |
| ▸ | CA2 | P00918 | 6/20 | 0.37 |
| ▸ | CA9 | Q16790 | 6/20 | 0.37 |
| ▸ | CASR | P41180 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ACP1 | P24666 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3895105 | 0.83 | NT5E (0.56) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL3895091 | 0.82 | NT5E (0.55) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL11436880 | 0.81 | CASP6 (0.56) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL11311222 | 0.81 | CASP6 (0.52) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL10900256 | 0.80 | PRMT1 (0.63) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL4022032 | 0.79 | CASP6 (0.49) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL3897862 | 0.79 | CASP6 (0.49) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL7093010 | 0.79 | APEX1 (0.41) | CASP6NT5EALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL3897328 | 0.78 | CASP6 (0.48) | CASP6PRMT1NT5ENSD2DUSP3 | |
| SCHEMBL20299286 | 0.77 | CASP6 (0.74) | CASP6PRMT1NT5ENSD2DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | claimed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | FUT6, B3GNT2, SIGLEC7 | CASP6 1129/4885PRMT1 1218/4885NT5E 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.